Mayo Clinic Laboratory and pathology research roundup: May 31

By Meghann Southwick • May 31, 2022

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Substance use screening in transplant populations: Recommendations from a consensus workgroup.

Transplant patients are frequently treated with substances that have dependence potential and/or they may have a history of substance use disorders. While use of certain substances may not result in the exclusion for transplantation, an awareness of the patient's practices and possible risk from substances is necessary, allowing transplant teams to screen for substance use disorders and ensure the patient is able to manage and minimize risks post-transplant.

Read more.

Published to PubMed This Week

• RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large cell lymphoma.
  Histopathology
• Management and outcomes of acute myocardial infarction-cardiogenic shock in uninsured compared with privately insured individuals
  Circulation. Heart failure
• Multiple Consecutive Cervicovaginal Cytology Specimens Confirm Persistent Colonization by Cokeromyces recurvatus: Case Report and Literature Review.
  Case reports in pathology
• The Clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC).
  Biomarkers
• Paraneoplastic neuronal intermediate filament presenting as encephalopathy and myoclonus: a case report and literature review.
  Journal of neurology
• Cyto-histologic correlation of crystal-storing histiocytosis: Rare presentation in breast, predating diagnosis of B-cell lymphoma by two years.
  Annals of diagnostic pathology
• A case of opsoclonus-myoclonus-ataxia with neuronal intermediate filament IgG detected in cerebrospinal fluid.
  Journal of neuro-ophthalmology

Meghann Southwick

Meghann Southwick is a marketing specialist for Mayo Clinic Laboratories. She has worked at Mayo Clinic since 2021.